3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
31
Squamous Cell Carcinoma of Head and Neck
21
Carcinoma, Non-Small-Cell Lung
20
Neoplasms
18
Breast Neoplasms
18
Glioblastoma
17
Esophageal Squamous Cell Carcinoma
16
Rectal Neoplasms
15
Lung Neoplasms
15
Esophageal Neoplasms
15
Head and Neck Neoplasms
12
Uterine Cervical Neoplasms
11
Neoplasm Metastasis
10
Glioma
10
Nasopharyngeal Carcinoma
8
Stomach Neoplasms
7
Radiation Injuries
7
Oropharyngeal Neoplasms
7
Brain Neoplasms
7
Hyperthermia
6
Carcinoma, Hepatocellular
6
Astrocytoma
6
Urinary Bladder Neoplasms
5
Small Cell Lung Carcinoma
5
Sarcoma
5
Oligodendroglioma
5
Colorectal Neoplasms
5
Carcinoma, Renal Cell
5
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Interventions
Temozolomide
2
venetoclax
1
etoposide phosphate
1
Vincristine
1
Thiotepa
1
Therapeutics
1
Telemedicine
1
Tamoxifen
1
Surveys and Questionnaires
1
Standard of Care
1
Radiotherapy
1
Patient Navigation
1
Mesna
1
Isotretinoin
1
Interviews as Topic
1
Immunotherapy, Adoptive
1
Hydrocortisone
1
Granulocyte Colony-Stimulating Factor
1
Genetic Testing
1
Filgrastim
1
Etoposide
1
Early Intervention, Educational
1
Drug Therapy
1
Cytarabine
1
Cyclophosphamide
1
Cisplatin
1
Celecoxib
1
Carboplatin
1
Blood Specimen Collection
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pyloric Stenosis, Hypertrophic
×
Radiotherapy
×
Clear all
NCT06861244
2026-04-23
PNOC031
University of California, San Francisco
Phase 2
Recruiting
70 enrolled